Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Vagal Approaches on Symptomatology in Long COVID Participants

NCT07190105 is registered in ClinicalTrials.gov with Leidos Life Sciences as lead sponsor.

NCT NCT07190105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07190105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Vagal Approaches on Symptomatology in Long COVID Participants
Lead sponsor
Leidos Life Sciences
Phase
Not applicable
Overall status
Completed
Start date
October 27, 2025
Completion date
December 11, 2025
Enrollment
546 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid symptoms